IRulya Therapeutics Inc.

IRLA · XNAS

CIK 1662774fmd_19E4P0V42K43F0WRQ1HK5F10N9Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2018 to Jun 30, 2026, 34 periods

Ratios computed from the standardized statements. Select a value to open its proof.